Literature DB >> 11487232

The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice.

N M Gades1, P J Danneman, S K Wixson, E A Tolley.   

Abstract

This study was designed to determine the magnitude and duration of the analgesic effect of three commonly used opioids: buprenorphine (0.5 mg/kg for rats; 2.0 mg/kg for mice), butorphanol (2.0 mg/kg for rats; 5.0 mg/kg for mice), and morphine (10 mg/kg for rats and mice). We used two standard tests, the hot plate and tail flick assays, to measure opioid analgesia in 62 male, 200 to 300 g Sprague-Dawley rats and 61 male, 25 to 35 g ICR mice. We obtained five baseline measurements then administered the drugs subcutaneously. Morphine gave the highest analgesic effect and was intermediate in duration (2 to 3 h in rats and mice) of analgesia. Butorphanol provided the lowest level of and shortest (1 to 2 h in rats and mice) analgesia. Buprenorphine had an intermediate analgesic effect and the longest duration (6 to 8 h in rats and 3 to 5 h in mice). In light of our results, we recommend the use of morphine (with frequent redosing) for severe pain, butorphanol for mild pain of short duration, and buprenorphine for mild to moderate pain of increased duration. The dosing intervals suggested by our study are 2 to 3 h for morphine in both rats and mice, 1 to 2 h for butorphanol in both rats and mice; and 6 to 8 h in rats and 3 to 5 h in mice for buprenorphine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11487232

Source DB:  PubMed          Journal:  Contemp Top Lab Anim Sci        ISSN: 1060-0558


  58 in total

1.  Testing and comparison of non-opioid analgesics in amphibians.

Authors:  C W Stevens; D N MacIver; L C Newman
Journal:  Contemp Top Lab Anim Sci       Date:  2001-07

2.  Effects of buprenorphine on a cecal ligation and puncture model in C57BL/6 mice.

Authors:  Tara M Cotroneo; Kelly M S Hugunin; Katherine A Shuster; Hae J Hwang; Bala N Kakaraparthi; Jean A Nemzek-Hamlin
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-05       Impact factor: 1.232

3.  Pharmacokinetics of sustained-release analgesics in mice.

Authors:  Lon V Kendall; Ryan J Hansen; Kathryn Dorsey; Sooah Kang; Paul J Lunghofer; Daniel L Gustafson
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-09       Impact factor: 1.232

4.  Efficacy of various analgesics on shoulder function and rotator cuff tendon-to-bone healing in a rat (Rattus norvegicus) model.

Authors:  Adam C Caro; Jennica J Tucker; Sarah M Yannascoli; Andrew A Dunkman; Stephen J Thomas; Louis J Soslowsky
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-03       Impact factor: 1.232

5.  Rodent models of osteoporosis.

Authors:  Antonia Sophocleous; Aymen I Idris
Journal:  Bonekey Rep       Date:  2014-12-10

6.  Analgesia and Humane Endpoints for Rodents in Sepsis Research.

Authors:  Christine A Boehm; Jean A Nemzek
Journal:  Methods Mol Biol       Date:  2021

7.  Pharmacokinetic Profiles of Nalbuphine after Intraperitoneal and Subcutaneous Administration to C57BL/6 Mice.

Authors:  Brenda L Kick; Pan Shu; Bo Wen; Duxin Sun; Douglas K Taylor
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-09-01       Impact factor: 1.232

8.  Clinical efficacy of buprenorphine to minimize distress in MRL/lpr mice.

Authors:  Julie Swenson; Selen Olgun; Ali Radjavi; Taranjit Kaur; Christopher M Reilly
Journal:  Eur J Pharmacol       Date:  2007-04-06       Impact factor: 4.432

9.  Effects of Standard and Sustained-release Buprenorphine on the Minimum Alveolar Concentration of Isoflurane in C57BL/6 Mice.

Authors:  Philip C LaTourette; Emily M David; Cholawat Pacharinsak; Katechan Jampachaisri; Jennifer C Smith; James O Marx
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-04-08       Impact factor: 1.232

10.  Analgesic Efficacy of Firocoxib, a Selective Inhibitor of Cyclooxygenase 2, in a Mouse Model of Incisional Pain.

Authors:  Balagangadharreddy Reddyjarugu; Todd Pavek; Teresa Southard; Jason Barry; Bhupinder Singh
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-07       Impact factor: 1.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.